Macrolide Drugs Market Report Reviews Drivers, Analysis, Share, Growth, Trends & Forecast to 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 14, 2020 (Heraldkeepers) —
The global Macrolide Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Macrolide Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

The Global Macrolide Drugs market is expected to exceed more than US$ 7.8 Billion by 2024 at a CAGR of 3.5% in the given forecast period.

Browse Full Report:

The global Macrolide Drugs market is segregated on the basis of Application as Hospitals, Clinics, Hospitals hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Based on Type the global Macrolide Drugs market is segmented in 14-Membered Ring Agents, 15-Membered Ring Agents, 16-Membered Ring Agents, and Ketolides.

The growing prevalence and recurrence of bacterial infections is expected to be the major factor driving the growth of the macrolide drug market over the forecast period. Growing elderly population is also one of the factors expected to surge the growth of the macrolide drug market. The side effects of macrolide drugs such as gastro intestinal disturbances, e.g., nausea, diarrhea, and vomiting, is projected to restrain the growth of the macrolide drug market over the forecast period.

The macrolide drugs are a group of antibiotics created by varied strains of Streptomyces (spore forming microorganism that grow slowly in soil or water as a branching thin plant structure like that of fungi) and have a complex chemical (macrocyclic) structure. They act by inhibiting protein synthesis, specifically by obstruction the 50S ribosomal subunit. They form a broad spectrum antibiotics.

Competitive Rivalry

Abbott Laboratories, Akorn, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT, and others are among the major players in the global Macrolide Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Macrolide Drugs Market has been segmented as below:

Macrolide Drugs Market, By Application

  • Hospitals

  • Clinics

  • Hospitals hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

Macrolide Drugs Market, By Type

  • 14-Membered Ring Agents

  • 15-Membered Ring Agents

  • 16-Membered Ring Agents

  • Ketolides

Macrolide Drugs Market, By Region

  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World

Macrolide Drugs Market, By Company

  • Abbott Laboratories

  • Akorn

  • Macrolide Pharmaceuticals

  • Mylan

  • Pfizer

  • Sanofi

  • Merck & Co.

  • Sandoz International

  • Teva Pharmaceutical Industries


The report covers:

  • Global Macrolide Drugs market sizes from 2015 to 2024, along with CAGR for 2018-2024

  • Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024

  • Global Macrolide Drugs market trends, covering comprehensive range of consumer trends & manufacturer trends

  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Macrolide Drugs market

  • Major market opportunities and challenges in forecast timeframe to be focused

  • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management

  • Comprehensive company profiles of the key industry players

Report Scope:

The global Macrolide Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Macrolide Drugs market share. Major industry players with significant revenue share include Abbott Laboratories, Akorn, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT, and others.

Reasons to Buy this Report:

  • Gain detailed insights on the Macrolide Drugs industry trends

  • Find complete analysis on the market status

  • Identify the Macrolide Drugs market opportunities and growth segments

  • Analyze competitive dynamics by evaluating business segments & product portfolios

  • Facilitate strategy planning and industry dynamics to enhance decision making

Request Sample Report from here:

Table of Contents:

  1. Introduction 1.1 Key Insights 1.2 Report Overview 1.3 Markets Covered 1.4 Stakeholders

  2. Research Methodology 2.1 Research Scope 2.2 Market Research Process 2.3 Research Data Analysis 2.4.1 Secondary Research 2.4.2 Primary Research 2.4.3 Models for Estimation 2.5 Market Size Estimation 2.5.1 Bottom-Up Approach – Segmental Market Analysis 2.5.2 Top-Down Approach – Parent Market Analysis

  3. Executive Summary

  4. Market Overview 4.1 Introduction 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.2.4 Challenges 4.2 Porter’s Five Force Analysis

  5. Macrolide Drugs Market, By Application

  6. Macrolide Drugs Market, By Type

  7. Macrolide Drugs Market, By Geography

  8. Competitive Insights 8.1 Key Insights 8.2 Company Market Share Analysis 8.3 Strategic Outlook 8.3.1 Mergers & Acquisitions 8.3.2 New Product Development 8.3.3 Portfolio/Production Capacity Expansions 8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements 8.3.5 Others

  9. Company Profiles 9.1 Abbott Laboratories 9.1.1 Company Overview 9.1.2 Product/Service Landscape 9.1.3 Financial Overview 9.1.4 Recent Developments 9.2 Akorn 9.2.1 Company Overview 9.2.2 Product/Service Landscape 9.2.3 Financial Overview 9.2.4 Recent Developments 9.3 Macrolide Pharmaceuticals 9.3.1 Company Overview 9.3.2 Product/Service Landscape 9.3.3 Financial Overview 9.3.4 Recent Developments 9.4 Mylan 9.4.1 Company Overview 9.4.2 Product/Service Landscape 9.4.3 Financial Overview 9.4.4 Recent Developments 9.5 Pfizer 9.5.1 Company Overview 9.5.2 Product/Service Landscape 9.5.3 Financial Overview 9.5.4 Recent Developments 9.6 Sanofi 9.6.1 Company Overview 9.6.2 Product/Service Landscape 9.6.3 Financial Overview 9.6.4 Recent Developments 9.7 Merck & Co. 9.7.1 Company Overview 9.7.2 Product/Service Landscape 9.7.3 Financial Overview 9.7.4 Recent Developments 9.8 Sandoz International 9.8.1 Company Overview 9.8.2 Product/Service Landscape 9.8.3 Financial Overview 9.8.4 Recent Developments 9.9 Teva Pharmaceutical Industries 9.9.1 Company Overview 9.9.2 Product/Service Landscape 9.9.3 Financial Overview 9.9.4 Recent Developments 9.10 WOCKHARDT 9.10.1 Company Overview 9.10.2 Product/Service Landscape 9.10.3 Financial Overview 9.10.4 Recent Developments

Other Related Market Research Reports:

Antidiarrheal Drugs Market 2019 Size, Industry Share, Approaches and Forecast By 2024 – MRE Report


Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [email protected]

Phone: +1-855-984-1862

Country: United States




Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Next Post

Chinese internet companies have less to lose when it comes to U.S. threats

Tue Sep 15 , 2020
Sheldon Cooper | LightRocket | Getty Images SINGAPORE — China’s internet companies may be more insulated from a fallout between the U.S. and China than telecommunication equipment companies like Huawei, a CLSA tech analyst told CNBC on Monday. That’s because they do not rely on international suppliers for parts and technology […]
Chinese internet companies have less to lose when it comes to U.S. threats

You May Like